These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 11055578

  • 1. Influence of the aliphatic spacer length on the 5-HT1A receptor activity of new arylpiperazines with an indazole system.
    Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E.
    Pol J Pharmacol; 2000; 52(3):209-16. PubMed ID: 11055578
    [Abstract] [Full Text] [Related]

  • 2. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
    Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E, Paluchowska MH.
    Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541
    [Abstract] [Full Text] [Related]

  • 3. Effect of linking bridge modifications on the 5-HT1A receptor activity of some 4-(omega-benzotriazol-1-yl)alkyl-1-(2-methoxy-phenyl)piperazines.
    Paluchowska MH, Kłodzińska A, Tatarczyńska E, Szaro A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998; 50(4-5):341-7. PubMed ID: 10091719
    [Abstract] [Full Text] [Related]

  • 4. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
    Mokrosz MJ, Boksa J, Charakchieva-Minol S, Wesołowska A, Borycz J.
    Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
    [Abstract] [Full Text] [Related]

  • 5. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ, Kowalski P, Kowalska T, Majka Z, Duszyńska B, Charakchieva-Minol S, Szaro A, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G, Pawłowski M, Duszyńska B, Szaro A, Tatarczńska E, Kłodzińska AL, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [Abstract] [Full Text] [Related]

  • 7. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH, Mokrosz MJ, Charakchieva-Minol S, Duszyńska B, Kozioł A, Wesołowska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [Abstract] [Full Text] [Related]

  • 8. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
    Boksa J, Mokrosz MJ, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Wesołowska A, Misztal S.
    Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069
    [Abstract] [Full Text] [Related]

  • 9. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
    Paluchowska MH, Bugno R, Charakchieva-Minol S, Bojarski AJ, Wesołowska A.
    Pol J Pharmacol; 2001; 53(4):369-76. PubMed ID: 11990083
    [Abstract] [Full Text] [Related]

  • 10. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
    Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E, Pawłowski M, Martinez J.
    Bioorg Med Chem; 2007 Apr 15; 15(8):2907-19. PubMed ID: 17321139
    [Abstract] [Full Text] [Related]

  • 11. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L, Estrada-Camarena E, López-Rubalcava C.
    Psychopharmacology (Berl); 2002 Dec 15; 165(1):60-6. PubMed ID: 12474119
    [Abstract] [Full Text] [Related]

  • 12. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA, Chou JM, Tang H, Frazer A.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):198-208. PubMed ID: 8035316
    [Abstract] [Full Text] [Related]

  • 13. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
    Boksa J, Klodzińska A, Charakchieva-Minol S, Chojnacka-Wójcik E, Mokrosz JL.
    Pharmazie; 1996 Feb 15; 51(2):72-6. PubMed ID: 8720802
    [Abstract] [Full Text] [Related]

  • 14. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF, Lesourd M, Mocaer E, Koolhaas JM.
    J Pharmacol Exp Ther; 1999 Mar 15; 288(3):1125-33. PubMed ID: 10027850
    [Abstract] [Full Text] [Related]

  • 15. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
    Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2004 Mar 15; 56(6):743-54. PubMed ID: 15662087
    [Abstract] [Full Text] [Related]

  • 16. Novel N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]-ethyl]pyrid-2(1H)-ones with diversified 5-HT1A receptor activity.
    Paluchowska MH, Bugno R, Charakchieva-Minol S, Wesołowska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2002 Mar 15; 54(6):641-6. PubMed ID: 12866719
    [Abstract] [Full Text] [Related]

  • 17. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
    Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A.
    Pol J Pharmacol; 1999 Mar 15; 51(5):415-21. PubMed ID: 10817542
    [Abstract] [Full Text] [Related]

  • 18. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2293-303. PubMed ID: 15727878
    [Abstract] [Full Text] [Related]

  • 19. Antagonism of (+)WAY 100135 to behavioral, hypothermic and corticosterone effects induced by 8-OH-DPAT.
    Przegaliński E, Filip M, Budziszewska B, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1994 Mar 15; 46(1-2):21-7. PubMed ID: 7981767
    [Abstract] [Full Text] [Related]

  • 20. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M, Caicoya AG, Greciano V, Benhamú B, López-Rodríguez ML, Fernández-Alfonso MS, Pozo MA, Manzanares J, Fuentes JA.
    Eur J Pharmacol; 2005 Mar 21; 511(1):9-19. PubMed ID: 15777774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.